Building Biological
Superintelligence
to End Disease
Digital patient models. Trillion-molecule screening. PhD-level AI scientists.
Built to actually understand science, Omic is the best way to research with AI.
#1 in Biology, Chemistry, and Physics Reasoning
Finally, AI that understands science
What is GPQA?
Graduate-level benchmark testing AI on biology, chemistry, and physics questions. Data via Artificial Analysis.
Our Approach
Specialized domain models + agentic reasoning + scientific tools. Optimized for biological and chemical reasoning in drug discovery.
Methodology
Accuracy on GPQA Diamond test set. Human PhD baseline (69.7%) from original paper. Competitor scores publicly reported as of November 2025.
An IDE for Science
An AI scientist that ideates with you, forms and tests hypotheses, builds and deploys research tools, runs iterative experiments, performs complex data analyses, and writes journal-ready manuscripts.
Conducts deep research and generates comprehensive scientific analyses
Software developers have 10Xed their productivity through LLM coding tools. Now it's our turn.
Optimized for Biomedical Discoveries
Autonomous agent that forms hypotheses, designs experiments, analyzes results, and iterates, discovering drugs through the scientific method
Fully Autonomous
No human intervention required. The AI forms novel hypotheses, designs protocols, executes experiments in silico, analyzes data, and refines its approach, just like a human scientist would.
Continuous Learning
Each iteration feeds back into the next cycle. Failed experiments inform new hypotheses. Successful results get optimized further. The system improves with every loop.
Making Users Extraordinarily Productive Across the Organization
Hundreds of specialized AI agents operating in parallel across discovery, clinical development, and cross-functional operations, transforming pharma into a computational discipline
Discovery to IND
Clinical Development
Business & Strategic
Cross-Org Capabilities
Operating in parallel across the entire drug discovery and development pipeline
Bring a lab of AI scientists to every question.
Start free and scale from a single student project to a full research lab. We're onboarding new researchers in batches. Request access and we'll send your invite shortly.
- ✦Full platform: literature, data analysis, deep research, hypotheses, writing
- ✦1 project / day
- ✦5 chat actions / day · 15 / week
- ✦7-day data storage
- ✦Community support
- ✦3 projects / day
- ✦25 chat actions / day · 150 / week
- ✦90-day data storage
- ✦API access
- ✦10 projects / day
- ✦Unlimited chat actions
- ✦Unlimited data storage
- ✦Priority compute & early access
- ✦Pooled usage across every seat
- ✦Shared workspace & member invites
- ✦Admin controls & usage dashboard
- ✦Pooled seat billing
- ✦Unlimited projects & chat
- ✦Digital patient pipelines
- ✦Virtual clinical trials
- ✦SSO / SAML & custom integrations
- ✦Dedicated support & SLAs
All plans run on the same PhD-level AI scientist. Questions? Talk to us →
Partner with Omic
Beyond self-serve plans, we take on the hardest problems in drug discovery and license AI-discovered assets
Bring Us Your Hardest Problems
Give us your target, your use case, what success looks like. We'll deploy AI scientists, integrate your data, build custom tools, and push science to its limits. Lock up validated targets. Get answers no one else can provide.
License AI-Discovered Assets
Four programs in oncology, infectious disease, cardiovascular, and hematology. Computationally validated, in lead optimization. Pick your indication, negotiate terms, move fast.
Explore ProgramsFrequently Asked Questions
Common questions about AI drug discovery and the Omic platform
What is Omic.ai?
Omic.ai is an AI-driven digital patient and multi-omics drug discovery platform. It combines biological superintelligence with computational biology to accelerate drug discovery through target identification, biomarker discovery, and generative compound screening.
How does Omic use AI for drug discovery?
Omic uses PhD-level AI scientists that can read scientific literature, form hypotheses, design experiments, analyze data, and discover drug targets autonomously. The platform achieves 93.3% accuracy on GPQA Diamond benchmark, outperforming GPT-5.1 and human PhD experts.
What are digital patient models?
Digital patient models are computational simulations that capture the molecular dynamics of disease. They allow Omic to predict drug response across diverse patient populations before synthesizing compounds, enabling precision medicine and reducing clinical trial failures.
What is the pricing for Omic?
Omic offers a free plan with full access to the AI scientist, then paid tiers as you scale: Student at $15/month, Researcher at $99/month, Lab at $129/seat/month for teams, and custom Enterprise pricing for pharma-scale drug discovery workflows and virtual clinical trials. Omic is currently onboarding new users by request. You can request early access from any plan.
What therapeutic areas does Omic focus on?
Omic has four active small-molecule programs, all in lead optimization: MYR-001 (myristoylation, for cancer and infectious disease), GLC-001 (glaucoma), IMO-001 (a trispecific for solid tumors), and GPR-001 (GPR55, for inflammatory pain and sickle-cell crises).